[S]  articles appearing in theoretical statistics
journals;

2017 94. [S] Ghiglietti, A., Vidyashankar, A. N., and Rosenberger, W. F. "Central Limit Theorems for an Adaptive Randomly Reinforced Urn Model," Annals of Applied Probability, in press. 93. [B] Vilar, S. S. and Rosenberger, W. F. "CovariateAdjusted ResponseAdaptive Randomizaiton for Multiarm Clinical Trials Using a Modified Forward Looking Gittins Index Rule," Biometrics, in press. 92. [I] Gerber, L. H., Sikdar, S., Aredo, J. V., Armstrong, K., Rosenberger, W. F., Shao, H., and Shah, J. P. "Beneficial Effects of Dry Needling for Treatment of Chronic Myofascial Pain Persist for 6 Weeks After Treatment Completion," Physical Medicine and Rehabilitation, 9, 105112. 91. [I] Waldstein, S., Dore, G. A., Davatzikos, C., Katzel, L. I., Gullapalli, R., Seliger, S. L., Kouo, T., Rosenberger, W. F., Erus, G., Evans, M. K., and Zonderman, A. B. "The Differential Associations of Socioeconomic Status with Brain Volumes in African Americans and Whites," Psychosomatic Medicine, 79, 327335.

2016 90. [B] Galbete, A. and Rosenberger, W. F. On the Use of Randomization Tests Following Adaptive Designs,” Journal of Biopharmaceutical Statistics, in press. 89. [I] Wendell, C. R., Zonderman, A. B., Katzel, L. I., Rosenberger, W. F., Plamadeala, V. V., Hosey, M. M., and Waldstein, S. R. "Nonlinear Associations Between Plasma Cholesterol Levels and Neuropsychology Function," Neuropsychology, 30, 980987. 88. [I] Moatti, M., Chevret, S., Zohar, S., and Rosenberger, W. F. “A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes,” Methods of Information in Medicine, in press. 87. [RP] Shao, H. and Rosenberger, W. F. “Properties of the Random Block Design for Clinical Trials,” In mODa11 – Advances in ModelOriented Design and Analysis, Heidelberg: PhysicalVerlag, in press.

2015 86. [S] Rosenberger, W. F. “A Conversation with Nancy Flournoy,” Statistical Science, 30, 133146. 85. [B] Kennes, L. N., Rosenberger, W. F., and Hilgers, R.D. “Inference for Blocked Randomization Under a Selection Bias Model,” Biometrics, in press. 84. [B] Baldi Antognini, A., Rosenberger, W. F., Wang, Y., and Zagoraiou, M. “Exact Optimum Coin Bias in Efron’s Randomization Procedure,” Statistics in Medicine, in press. 83. [B] Galbete, A. and Rosenberger, W. F. On the Use of Randomization Tests Following Adaptive Designs,” Journal of Biopharmaceutical Statistics, in press. 82. [I] Turo, D., Otto, P., Hossain, M., Gebreab, T., Armstrong, K., Rosenberger, W. F., Shao, H., Shah, J. P., Gerber, L. H., and Sikdar, S. “Novel Use of Ultrasound Elastography to Quantify Muscle Tissue Changes After Dry Needling of Myofascial Trigger Points in Patients with Chronic Myofascial Pain,” Journal of Ultrasound in Medicine, in press. 81. [I] Sims Wright, R. C., Levy, S. T. Katzel, L. I., Rosenberger, W. F., Manukyan, Z., Whitfield, K. E., and Waldstein, S. R. “Fasting Glucose, Glucose Tolerance, and Neurocognitive Function Relations Among Nondiabetic Older Adults,” Journal of Clinical and Experimental Neuropsychology, in press.

2014 80. [B] Parhat, P., Rosenberger, W. F., and Diao, G. “Conditional Monte Carlo Randomization Tests for Regression Models,” Statistics in Medicine, 33, 30783088. 79. [B] Dong, T., Tang, L. L., and Rosenberger, W. F. “Optimal Sampling Ratios in Comparative Diagnostic Trials,” Journal of the Royal Statistical Society C, 63, 499514. 78. [I] Hu, F., Hu, Y., Ma, Z., and Rosenberger, W. F. “Adaptive Randomization for Balancing on Covariates,” WIREs: Computational Statistics, 6, 288303. 77. [I] Sims, R. C., Katzel, L. I., Lefkowitz, D. M., Siegel, E. L., Rosenberger, W. F., Manukyan, Z., Whitfield, K. E., and Waldstein, S. R. “Association of Fasting Glucose with Subclinical Cerebrovascular Disease Among Nondiabetic Older Adults,” Diabetic Medicine, 6, 691698.

2013 76. [S] Sverdlov, O. and Rosenberger, W. F. “On Recent Advances in Optimal Allocation Designs in Clinical Trials,” Journal of Statistical Theory and Practice, 7(4), 753773. 75. [S] Flournoy, N., Haines, L. M., and Rosenberger, W. F. “A Graphical Comparison of ResponseAdaptive Randomization Procedures,” Statistics in Biopharmaceutical Research, 5, 126141. 74. [B] Sverdlov, O., Rosenberger, W. F., and Ryeznik, Y. “Utility of CovariateAdjusted ReponseAdaptive Randomization in Survival Trials,” Statistics in Biopharmaceutical Research, 5, 3853. 73. [B] Flournoy, N., Haines, L. M., and Rosenberger, W. F. “A Graphical Comparison of ResponseAdaptive Randomization Procedures,” Statistics in Biopharmaceutical Research, in press. 72. [I] Sverdlov, O. and Rosenberger, W. F. “Randomization in Clinical Trials: Can We Eliminate Bias?” Clinical Investigation, 3(1), 3747.

2012 71. [S] Plamadeala, V. and Rosenberger, W. F. “Sequential Monitoring With Conditional Randomization Tests,” Annals of Statistics, 40, 3044. 70. [B] Rosenberger, W. F., Sverdlov, O., and Hu, F. “Adaptive Randomization for Clinical Trials,” Journal of Biopharmaceutical Statistics, 22, 719736. 69. [I] Walstein, S. R., Wendell, C. R., Lefkowitz, D. M., Siegel, E. L., Rosenberger, W. F., Spencer, R. J., Manukyan, Z., and Katzel, L. I. “Interactive Relations of Blood Pressure and Age to Subclinical Cerebrovascular Disease,” Journal of Hypertension, in press.

2010 68. [S] Markaryan, T. and Rosenberger, W. F. “Exact Properties of Efron’s Biased Coin Randomization Procedure,” Annals of Statistics, 38, 15461567. 67. [I] Palsbo, S. E., Diao, G., Palsbo, G. A., Tang, L., Rosenberger, W. F., Mastal, M. F. “Casemix Adjustment and Enabled Reporting of the Health Care Experiences of Adults with Disabilities,” Archives of Physical Medicine and Rehabilitation, 91, 13391346.. 66. [I] Rice, S. C., Hosey, M. M., Lefkowitz, D. M., Katzel, L. I., Siegel, E. L., Rosenberger, W. F., Waldstein, S. R. “Depressive Symptoms are Associated with Subclinical Neurovascular Disease Among Healthy Older Women, Not Men.” American Journal of Geriatric Psychiatry, 18, 940947. 65. [I] Waldstein, S. R., Lefkowitz, D. M., Siegel, E. L., Rosenberger, W. F., Spencer, R. J., Tankard, C. F., Manukyan, Z., Gerber, E. J., and Katzel, L. I. “Reduced Cerebral Blood Flow in Older Men with Higher Levels of Blood Pressure.” Journal of Hypertension, 28, 993998. 64. [RP] Manukyan, Z. and Rosenberger, W. F. “DOptimal Design for a FiveParameter Logistic Model,” In Giovagnoli, A., Atkinson, A. C., and Torsney, B. (eds.), mODa9 Advances in Model Oriented Design and Data Analysis, Heidelberg: PhysicaVerlag, 113120.

2009 63. [S] Roy, A., Ghosal, S., and Rosenberger, W. F. “Convergence Properties of Sequential Bayesian DOptimal Designs,” Journal of Statistical Planning and Inference, 139, 425440. 62. [B] Liu, G., Rosenberger, W. F., and Haines, L. M. “Sequential Designs for Ordinal Phase I Clinical Trials,” Biometrical Journal, 51, 335347. 
61. [S] Rosenberger, W. F. and Sverdlov, O. "Handling Covariates in the Design of Clinical Trials," Statistical Science, 23, 404419. 60. [S] Zhang, Y. and Rosenberger, W. F. "Sequential Monitoring of Conditional Randomization Tests: Generalized Biased Coin Designs," Sequential Analysis , 27, 234253. 2007 
58. [B] Zhang, L. and Rosenberger, W. F. "ResponseAdaptive Randomization for Survival Trials," Journal of the Royal Statistical Society C, 53, 153165.
57. [B] Zhang, Y.,
Rosenberger, W. F., and Smythe, R. T. "Sequential Monitoring of
Randomization Tests: Stratified Randomization," Biometrics, 63,
865872. 
2006 

2005 

2004 
50. [B] Paul,
R. K. , Rosenberger, W. F., and Flournoy, N. "Nonparametric
Estimation of Multiple Quantiles Following Nonparametric Phase I Clinical Trial
Designs," Statistics in Medicine ,
23, 24832495.

49. [B] Mugno, R., Zhu, W., and
Rosenberger, W. F. "Adaptive Urn Designs for Estimating Several Percentiles of
a DoseResponse Curve," Statistics in
Medicine, 23, 21372150 .

48. [I] Rosenberger, W. F. and Hu,
F. "Maximizing Power and Minimizing Treatment Failures in Clinical
Trials," Clinical Trials, 1, 141147
.

47. [RP]
Tymofyeyev, Y., Rosenberger, W. F., and Hu. F. "Asymptotic
Properties of Urn Designs for ThreeArm Clinical Trials, in
mODa7 Advances in Model Oriented Design and Data Analysis,
2003 
46. [S] Hu, F. and Rosenberger, W.
F. "Optimality, Variability, Power: Evaluating ResponseAdaptive
Randomization Procedures for Treatment Comparisons,"
Journal of the American Statistical Association, 98, 671678
.

45. [S] Rosenberger, W. F. and Rukhin, A.
L. "Bias Properties and Nonparametric Infererence for Truncated Binomial
Randomization," Journal of
Nonparametric Statistics, 15, 455465.
44. [S] Perevozskaya, 
43. [B] Haines, L. M.,
Perevozskaya,
2002 
42. [S] Bai, Z. D., Hu, F, Rosenberger,
W. F. "Asymptotic Properties of Adaptive Designs with Delayed Response,"
Annals of Statistics, 30, 122139.

41. [S] Rosenberger, W. F.
"Randomized Urn Models and Sequential Design,"
Sequential Analysis (with discussion), 21, 141.

40. [S] Rosenberger, W. F. and Hu.
M. "On the Use of Generalized Linear Models Following a Sequential
Design," Statistics and Probability Letters,
56, 155161.

39. [B] Rosenberger, W. F. and
Haines, L. M. "Competing Designs for Phase I Clinical Trials: A Review,"
Statistics in Medicine, 21, 27572770.

38. [B] Stallard, N., Rosenberger, W.
F. "Exact GroupSequential Designs for Clinical Trials With Randomized
PlaytheWinner Allocation," Statistics in
Medicine, 21, 467480.
2001 
37. [B] Rosenberger, W. F., Stallard,
N., Ivanova, A.,
Harper, C., and Ricks, M.
"Optimal Adaptive Designs for Binary Response Trials,"
Biometrics, 57, 909913.

36. [B] Rosenberger, W. F.,
Vidyashankar, A. N., Agarwal, D. K.
"CovariateAdjusted ResponseAdaptive Designs for Binary Response,"
Journal of Biopharmaceutical Statistics, 11, 227236.

35. [I] Ivanova,
A. and Rosenberger, W. F. "Adaptive Designs for Clinical Trials
with Highly Successful Treatments," Drug
Information Journal, 35, 10871093.

34. [RP] Rosenberger, W. F., Haines, L. M.,
Perevozskaya, I. (2001). "Constrained Bayesian Optimal
Designs for Phase I Clinical Trials: Continuous Dose Space," in Atkinson,
A. C., Hackl, P., and Mueller, W. G. (eds.),
mODa6 Advances in Model Oriented Design and Data Analysis,

33. [RP] Haines, L. M., Clarke, G. P. Y., Gouws, E.,
and Rosenberger, W. F. (2001). "Optimal Design for the Testing of
AntiMalarial Drugs," in Atkinson, A. C., Hackl, P., and Mueller, W. G. (eds.),
mODa6 Advances in Model Oriented Design and Data Analysis,
Heidelberg: PhysicaVerlag, pp. 119126.
2000 
32. [S] HughesOliver, J. M. and
Rosenberger, W. F. "Efficient Estimation of the Prevalence of Multiple
Rare Traits," Biometrika, 87,
315327. 
31. [S] Hu, F., Rosenberger, W. F., and
Zidek, J. V. "Relevance Weighted Likelihood for Dependent Data,"
Metrika, 51, 223243.

30. [S]
Ivanova, A. V., Rosenberger, W. F.,

29. [B] Hu, F., Rosenberger, W.
F. "Analysis of Time Trends in Adaptive Designs with Application to a
Neurophysiology Experiment," Statistics in
Medicine, 19, 20672075.

28. [B] Ivanova,
A. V. and Rosenberger, W. F. "A Comparison of Urn Designs for
Randomized Clinical Trials of Treatments,"
Journal of Biopharmaceutical Statistics, 10, 93107.
1999 
27. [S] Rosenberger, W. F. and
HughesOliver, J. M. "Inference From a Sequential Design: Proof of
a Conjecture by Ford and Silvey," Statistics
and Probability Letters, 44, 177180.
Acknowledgment of Priority published 2001.

26. [B] Rosenberger, W. F. and Hu, F. "Bootstrap Methods for Adaptive Designs," Statistics in Medicine, 18, 17571767. 
25. [B] Coad, D. S. and Rosenberger, W. F. "A Comparison of the Randomised PlaytheWinner Rule and the Triangular Test for Clinical Trials With Binary Responses," Statistics in Medicine, 18, 761769. 
24. [I] Rosenberger, W. F. "Randomized PlaytheWinner Clinical Trials: Review and Recommendations," Controlled Clinical Trials, 20, 328342. 
23. [I] Palmer, C. R. and Rosenberger, W. F. "Ethics and Practice: Alternative Designs for Phase III Randomized Clinical Trials," Controlled Clinical Trials, 20, 172186. 
1998

22. [I] Grill, S. E.,
Rosenberger, W. F., Boyle, K., Cannon, M., and Hallett, M. "Perception of
Timing of Kinesthetic Stimuli," NeuroReport,
9, 40014005.

21. [RP] Mats,
V. A., Rosenberger, W. F., and Flournoy, N. "Restricted
Optimality for Phase I Clinical Trials," in Flournoy, N., Rosenberger, W. F.,
and Wong, W. K. (eds.), New Developments and
Applications in Experimental Design, Hayward, CA: Institute of
Mathematical Statistics, pp. 5061.

1997

20. [S] Rosenberger, W. F., Flournoy, N.,
and
19. [S] Rosenberger, W. F., Sriram, T. N. "Estimation for an Adaptive Allocation Design," Journal of Statistical Planning and Inference, 59, 309319. 18. [S] Matthews, P. C. and Rosenberger, W. F. "Variance in Randomized PlaytheWinner Clinical Trials," Statistics and Probability Letters, 35, 233240. 17. [B] 16. [B] Rosenberger, W. F. and Grill, S. E. "A Sequential Design for Psychophysical Experiments: An Application to Estimating Timing of Sensory Events," Statistics in Medicine, 16, 22452260. 
15. [B] Rosenberger, W. F. and
Seshaiyer, P. (1997). "Adaptive Survival Trials,"
Journal of Biopharmaceutical Statistics, 7, 617624.
14. [I] Flowers, J. L., Jacobs, J., Cho, E., Morton, A., Rosenberger, W. F., Evans, D., Imbembo, A. L., Bartlett, S. T. "Comparison of Open and Laparoscopic Live Donor Nephrectomy," Annals of Surgery, 226, 483490 (with discussion). 1996 
13. [S] Rosenberger, W. F. "New
Directions in Adaptive Designs," Statistical
Science, 11, 137149.
12. [I] Rosenberger, W. F. "Dealing With Multiplicities in Pharmacoepidemiologic Studies," Pharmacoepidemiology and Drug Safety, 5, 95100. 
1995

11. [S] Flournoy, N.,
10. [B] Lan, K. K. G., Rosenberger, W. F., and Lachin, J. M. "Sequential Monitoring of Survival Data With the Wilcoxon Statistic," Biometrics, 51, 11751183. 9. [B] Rosenberger, W. F., Lachin, J. M., and Bain, R. P. "Nonparametric Test of Stochastic Ordering for Multiple Longitudinal Measures," Journal of Biopharmaceutical Statistics, 5, 235243. 8. [RP] Smythe, R. T. and Rosenberger, W. F. "PlaytheWinner Designs, Generalized Polya Urns, and Markov Branching Processes," in Flournoy, N. and Rosenberger, W. F. (eds.), Adaptive Designs, 7. [RP] Rosenberger, W. F. "Adaptive Designs in Clinical Trials: Some Issues With Emphasis on Asymptotic Inference," in Flournoy, N. and Rosenberger W. F. (eds.), Adaptive Designs, 1993 
6. [S] Rosenberger, W. F.
"Asymptotic Inference With ResponseAdaptive Treatment Allocation Designs,"
The Annals of Statistics, 21, 20982107.

5. [B] Lan, K. K. G.,
Rosenberger, W. F., and Lachin, J. M. "Use of Spending Functions for
Occasional or Continuous Monitoring of Data in Clinical Trials,"
Statistics in Medicine, 12, 22192231.

4. [I] Rosenberger, W. F. and Lachin, J.
M. (1993). "The Use of ResponseAdaptive Designs in Clinical
Trials," Controlled Clinical Trials,
14, 471484.
Pre1993 (before doctorate) 3. [B] Baker, S. G., Rosenberger, W. F., and DerSimonian, R. (1992). "ClosedForm Estimates for Missing Counts in TwoWay Contingency Tables," Statistics in Medicine, 11, 643657. 
2. [I] Patterson, B. H., Block, G., Rosenberger, W. F., Pee, D., and Kahle, L. L. (1990). "Fruits and Vegetables in the American Diet: Data from the NHANES II Survey," American Journal of Public Health, 80, 14431449. 
1. [I] Block, G., Rosenberger, W. F., and
Patterson, B. H. (1988). "Calories, Fat, and Cholesterol:
Intake Patterns in the
